# BRIEFING — 2026-10-17T10:55:00Z

## Mission
Adversarially challenge Milestone B1 deliverables (literature matrix, claim verification, novelty gap report) for empirical rigor, positive control labeling, citation integrity, and unbacked claims.

## 🔒 My Identity
- Archetype: challenger
- Roles: critic, specialist
- Working directory: C:\Users\hp\.gemini\antigravity\scratch\telomerase-research\.agents\teamwork\challenger_b1_2
- Original parent: 88e47d9f-fec7-4040-a371-fffc850c96fd
- Milestone: Milestone B1
- Instance: 2 of 2

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code
- Adversarial challenge: stress-test assumptions, find failure modes, propose counter-examples
- Run verification tests directly (`python -m pytest tests/ -v`)
- Verify positive controls (Arg774-Glu168, Lys78-Glu215, Leu183) marked as Positive Controls
- Test for unvalidated novel assertions without literature backing
- Verify schema conformance and complete citations in literature matrix
- Deliver verdict (APPROVE or REQUEST_CHANGES) in handoff.md and send_message

## Current Parent
- Conversation ID: 88e47d9f-fec7-4040-a371-fffc850c96fd
- Updated: 2026-10-17T10:47:37Z

## Review Scope
- **Files reviewed**: `results/literature/prior_art_matrix.csv`, `results/literature/claim_verification.md`, `results/literature/novelty_gap_report.md`
- **Related evidence**: `results/audit/evidence_ledger.csv`, `results/audit/repository_inventory.md`, `results/tables/residue_correspondence_tpp1.csv`
- **Review criteria**: schema compliance, positive control attribution, unbacked novel assertion detection, citation accuracy, empirical pytest pass

## Attack Surface
- **Hypotheses tested**:
  - H_alt1: Did the pipeline sneak in unvalidated mechanistic claims (such as zero allostery or sequential induced fit) under the guise of "novel findings"? -> REJECTED. Both claims are explicitly classified as `Unvalidated Proposal`, status `Contradicted` / `Untested`, and dismantled in `novelty_gap_report.md`.
  - H_alt2: Are canonical interactions (Arg774-Glu168, Lys78-Glu215, Leu183) claimed as new discoveries? -> REJECTED. All three are strictly classified as `Positive Control` across `prior_art_matrix.csv`, `claim_verification.md`, and `novelty_gap_report.md`.
  - H_alt3: Does `prior_art_matrix.csv` suffer from missing citations, malformed schema, or unreferenced proposals? -> REJECTED. 22 rows conform strictly to schema with 0 missing cells and complete primary literature citations.
  - H_alt4: Does the test suite fail after worker_b1's sequence mapping fix? -> REJECTED. `python -m pytest tests/ -v` passed 300/300 tests in 324.50s.
- **Vulnerabilities found**: None in the B1 literature deliverables. The literature audit successfully corrected and quarantined the speculative claims from Gen1.
- **Untested angles**: Milestone B2 independent structural recalculation engine (to be evaluated in Milestone B2).

## Loaded Skills
- None explicitly assigned in dispatch

## Key Decisions Made
- Confirmed that positive controls (Arg774-Glu168, Lys78-Glu215, Leu183) are correctly marked as Positive Controls.
- Verified that all novel assertions in `prior_art_matrix.csv` are strictly restricted to mathematical/computational parameterizations (multi-threshold contact matrix, SVD domain displacement decomposition, Lys170 peak remodeling magnitude) rather than unbacked biological claims.
- Verified schema and citations in `prior_art_matrix.csv`.
- Executed full test suite (`python -m pytest tests/ -v`): 300 passed, 0 failed.
- Verdict: APPROVE.

## Artifact Index
- `DISPATCH.md` — incoming dispatch records
- `BRIEFING.md` — persistent state and identity
- `progress.md` — liveness heartbeat and step tracker
- `handoff.md` — final evaluation report and verdict
